Allstate Corporation’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.27M | Buy |
|
|||||
|
2024
Q4 | $894K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.24M | Buy |
|
|||||
|
2022
Q3 | $1.03M | Buy |
|
|||||
|
2022
Q2 | $699K | Sell |
|
|||||
|
2022
Q1 | $1.32M | Sell |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | $1.01M | Sell |
|
|||||
|
2021
Q2 | $986K | Sell |
|
|||||
|
2021
Q1 | $874K | Buy |
|
|||||
|
2020
Q4 | $678K | Sell |
|
|||||
|
2020
Q3 | $801K | Sell |
|
|||||
|
2020
Q2 | $838K | Sell |
|
|||||
|
2020
Q1 | $732K | Sell |
|
|||||
|
2019
Q4 | $1.73M | Hold |
|
|||||
|
2019
Q3 | $1.21M | Buy |
|
|||||
|
2019
Q2 | $271K | Sell |
|
|||||
|
2019
Q1 | $639K | Buy |
|
|||||
|
2018
Q4 | $496K | Buy |
|